Effects of Porcine Pancreatic Enzymes on the Pancreas of Hamsters. Part 2: Carcinogenesis Studies

  • Fumiaki Nozawa Eppley Institute for Research in Cancer and Allied Diseases. Omaha, NE, USA
  • Mehmet Yalniz Eppley Institute for Research in Cancer and Allied Diseases. Omaha, NE, USA
  • Murat Saruc Gastroentero-Hepatology Division, Department of Internal Medicine, Celal Bayar University School of Medicine. Manisa, Turkey
  • Jens Standop Department of Surgery, Rheinsche Friedrichi-Wilhelms-University. Bonn, Germany
  • Hiroshi Egami Department of Gastroenterological Surgery, Graduate School of Medical Science, Kumamoto University. Kumamoto, Japan
  • Parviz M Pour Eppley Institute for Research in Cancer and Allied Diseases. Omaha, NE, USA
Keywords: Cell Proliferation, Glucose, Insulin, Pancreatic Neoplasms /prevention and control


Context Our previous study suggested that porcine pancreatic extract in hamsters with peripheral insulin resistance, normalizes insulin output, islet size and pancreatic DNA synthetic rate. It also inhibited the growth of human pancreatic cancer cells in nude mice. Objective To examine the potential value of the porcine pancreatic extract in controlling pancreatic carcinogenesis in this model, the present experiment was performed. Design Hamsters were fed a high fat diet and four weeks later when insulin resistance emerges, they were divided into two groups. One group received 1 g/kg BW of porcine pancreatic extract in drinking water and the other group received tap water. One week later, when insulin output normalizes in porcine pancreatic extract-treated hamsters, a single subcutaneous injection of N-nitrosobis-(2-oxopropyl) amine (BOP) at a dose of 40 mg/kg BW was given to all hamsters. The experiment was terminated at 43 weeks after the porcine pancreatic extract treatment. The number and size of pancreatic tumors, blood glucose, insulin, amylase and lipase levels, the average size of islets and the number of insulin cells/islets were determined. Results The incidence of pancreatic cancer was significantly lower in the porcine pancreatic extract group (P=0.043), as well as the plasma insulin level and the size of the islets in the porcine pancreatic extract group were significantly lower (P<0.001) than in the control group. No significantly differences were found in the glucose level between the groups. Conclusion These results show that porcine pancreatic extract has a potential to inhibit pancreatic cancer growth.

Image: Eppley Institute for Research in Cancer and Allied Diseases. Omaha, NE, USA.


Download data is not yet available.


Longnecker DS, Shinozuka H, Dekker A. Focal acinar cell dysplasia in human pancreas. Cancer 1980;45:534-540.

Pour PM. Experimental pancreatic cancer. Am J Surg Pathol 1989;13 Suppl 1:96-103.

Pour P. Islet cells as a component of pancreatic ductal neoplasms. I. Experimental study: ductular cells, including islet cell precursors, as primary progenitor cells of tumors. Am J Pathol 1978;90:295-316.

Pour PM. Histogenesis of exocrine pancreatic cancer in the hamster model. Environ Health Perspect 1984;56:229-243.

Pour P, Wilson R. Experimental pancreas tumor. in Moossa A (ed): Cancer of the pancreas. Baltimore: Williams & Wilkins, 1980, 37-158.

Egami H, Takiyama Y, Chaney WG, Cano M, Fujii H, Tomioka T, Metzgar R, Pour PM. Comparative studies on expression of tumor-associated antigens in human and induced pancreatic cancer in Syrian hamsters. Int J Pancreatol 1990;7:91-100.

Pour PM, Egami H, Takiyama Y. Patterns of growth and metastases of induced pancreatic cancer in relation to the prognosis and its clinical implications. Gastroenterology 1991;100:529-536.

Takiyama Y, Egami H, Pour PM. Expression of human tumor-associated antigens in pancreatic cancer induced in Syrian hamsters. Am J Pathol 1990;136:707-715.

Fujii H, Egami H, Chaney W, Pour P, Pelling J. Pancreatic ductal adenocarcinomas induced in Syrian hamsters by N-nitrosobis(2-oxopropyl)amine contain a c-Ki-ras oncogene with a point-mutated codon 12. Mol Carcinog 1990;3:296-301.

Mogaki M, Hirota M, Chaney WG, Pour PM. Comparison of p53 protein expression and cellular localization in human and hamster pancreatic cancer cell lines. Carcinogenesis 1993;14:2589-2594.

Pour P, Mohr U, Cardesa A, Althoff J, Kruger FW. Pancreatic neoplasms in an animal model: morphological, biological, and comparative studies. Cancer 1975;36:379-389.

Pour PM, Schmied BM. One thousand faces of Langerhans islets. Int J Pancreatol 1999;25:181-193.

Pour PM, Kazakoff K. Stimulation of islet cell proliferation enhances pancreatic ductal carcinogenesis in the hamster model. Am J Pathol 1996;149:1017-1025.

Birt DF, Pour PM. Increased tumorigenesis induced by N-nitrosobis(2-oxopropyl)amine in Syrian golden hamsters fed high-fat diets. J Natl Cancer Inst 1983;70:1135-1138.

Bell RH, Jr., Sayers HJ, Pour PM, Ray MB, McCullough PJ. Importance of diabetes in inhibition of pancreatic cancer by streptozotocin. J Surg Res 1989;46:515-519.

Pour PM, Kazakoff K, Carlson K. Inhibition of streptozotocin-induced islet cell tumors and N-nitrosobis(2-oxopropyl)amine-induced pancreatic exocrine tumors in Syrian hamsters by exogenous insulin. Cancer Res 1990;50:1634-1639.

Birt DF, Julius AD, White LT, Pour PM. Enhancement of pancreatic carcinogenesis in hamsters fed a high-fat diet ad libitum and at a controlled calorie intake. Cancer Res 1989;49:5848-5851.

Schneider MB, Matsuzaki H, Haorah J, Ulrich A, Standop J, Ding XZ, Adrian TE, Pour PM. Prevention of pancreatic cancer induction in hamsters by metformin. Gastroenterology 2001;120:1263-1270.

Permert J, Adrian TE, Jacobsson P, Jorfelt L, Fruin AB, Larsson J. Is profound peripheral insulin resistance in patients with pancreatic cancer caused by a tumor-associated factor? Am J Surg 1993;165:61-66; discussion 66-67.

Saruc M, Standop S, Standop J, Nozawa F, Itami A, Pandey KK, Batra SK, Gonzalez NJ, Guesry P, Pour PM. Pancreatic enzyme extract improves survival in murine pancreatic cancer. Pancreas 2004;28:401-412.

Permert J, Ihse I, Jorfeldt L, von Schenck H, Arnqvist HJ, Larsson J. Pancreatic cancer is associated with impaired glucose metabolism. Eur J Surg 1993;159:101-107.

Permert J, Larsson J, Fruin AB, Tatemoto K, Herrington MK, von Schenck H, Adrian TE. Islet hormone secretion in pancreatic cancer patients with diabetes. Pancreas 1997;15:60-68.

Lankisch PG. Enzyme treatment of exocrine pancreatic insufficiency in chronic pancreatitis. Digestion 1993;54 Suppl 2:21-29.

Layer P, Keller J, Lankisch PG. Pancreatic enzyme replacement therapy. Curr Gastroenterol Rep 2001;3:101-108.

FitzSimmons SC, Burkhart GA, Borowitz D, Grand RJ, Hammerstrom T, Durie PR, Lloyd-Still JD, Lowenfels AB. High-dose pancreatic-enzyme supplements and fibrosing colonopathy in children with cystic fibrosis. N Engl J Med 1997;336:1283-1289.

Mac Sweeney EJ, Oades PJ, Buchdahl R, Rosenthal M, Bush A. Relation of thickening of colon wall to pancreatic-enzyme treatment in cystic fibrosis. Lancet 1995;345:752-756.

Bansi DS, Price A, Russell C, Sarner M. Fibrosing colonopathy in an adult owing to over use of pancreatic enzyme supplements. Gut 2000; 46:283-285.

Hsu SM, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981;29:577-580.

Saruc M, Nozawa F, Yalniz M, Itami A, Pour PM. Effects of porcine pancreatic enzymes on the pancreas of hamsters. Part 1: Basic studies. JOP. J Pancreas (Online) 2012; 13:xxx-xxx.

Pour PM, Kazakoff K, Dulany K. A new technique for simultaneous demonstration of 4 tumor-associated antigens in pancreatic cancer cells. Zentralbl Pathol 1994;140:397-401.

Reddy S, Stefanovic N, Karanam M. Prevention of autoimmune diabetes by oral administration of syngeneic pancreatic extract to young NOD mice. Pancreas 2000;20:55-60.

Eppley Institute for Research in Cancer and Allied Diseases. Omaha, NE, USA
How to Cite
NozawaF., YalnizM., SarucM., StandopJ., EgamiH., & PourP. (2012). Effects of Porcine Pancreatic Enzymes on the Pancreas of Hamsters. Part 2: Carcinogenesis Studies. JOP. Journal of the Pancreas, 13(5), 482-487. https://doi.org/10.6092/1590-8577/663